Cspc baike shandong biopharmaceutical co ltd
WebCSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd. Company Profile Yantai, Shandong, China Competitors, Financials & Contacts - Dun & Bradstreet. Find … WebNov 24, 2024 · Developer CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.; Synermore Biologics Class Antiallergics; Antiasthmatics; Monoclonal antibodies; Skin …
Cspc baike shandong biopharmaceutical co ltd
Did you know?
WebJul 24, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Collaborator. Beijing Friendship Hospital; Provider of Information About this Clinical Study Sponsor; Overall Official(s) ... ID Number: CSPC-JYL-HLH-01. NCT Identifier: NCT04500886. NCT04500886, March 29, 2024. WebJan 9, 2024 · January 20, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Prospective, Open, One-arm Clinical Study Evaluating the Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced …
http://cspcbaike.en.drugdu.com/company_profile.html http://cspcbaike.en.drugdu.com/company_profile.html
WebJul 27, 2024 · August 2, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Multi-center, Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of the Prophylactic Use of Pegylated Recombinant Human Granulocyte Colony Stimulating Factor After Chemotherapy in Children With Hematological Malignancies WebAbout us. Website. http://cspc.com.hk. Industries. Pharmaceutical Manufacturing. Company size. 10,001+ employees. Headquarters. Shijiazhuang.
http://cspcbaike.en.drugdu.com/
WebJun 15, 2024 · Sponsors: Lead Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Source: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Brief Summary: The primary objective of this trial is to evaluate the efficacy of different doses and frequencies of administration of TG103 injection in the treatment of type 2 diabetes. small town smocksWebSep 14, 2024 · September 23, 2024 updated by: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Mellitus small town smallhttp://cspc.com.br/ highy rated smothie makerWebOct 23, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Save Print Send. Updated on 23 October 2024. See if I qualify. Summary. Show definitions. A multicenter, open, one-arm clinical study evaluated the efficacy and safety of Jinyouli in preventing neutropenia after chemotherapy in elderly lymphoma patients who met the criteria for … small town small lyrics jason aldeanWebJun 29, 2024 · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. ClinicalTrials.gov Identifier: NCT04944602 Other Study ID Numbers: SYSA1903-CSP-002 : First Posted: … small town skiingWebAnd CSPC have 16 CEP certificates and 33 DMF registration now. And 25 products of CSPC have passed the US FDA on-site inspection. As a national innovative enterprise, … highy rated notebook computersWebMay 25, 2024 · e22501 Background: The aims of the study were to investigate the pharmacokinetics and pharmacodynamics of pegylated recombinant human granulocyte colony stimulating factor(PEG-rhG-CSF) in pediatric patients with acute lymphoblastic leukemia(ALL), and compare the efficacy and safety of PEG-rhG-CSF (brand … small town small minds